PROTEIN-BINDING OF CEFTRIAXONE - COMPARISON OF 3 TECHNIQUES OF DETERMINATION AND THE EFFECT OF 2-HYDROXYBENZOYLGLYCINE, A DRUG-BINDING INHIBITOR IN UREMIA

被引：12

作者：

FISET, C

VALLEE, F

LEBEL, M

BERGERON, MG

机构：

[1] UNIV LAVAL,CTR HOSP,SERV INFECTIOL,2705 BOUL LAURIER,QUEBEC CITY G1V 4G2,QUEBEC,CANADA

[2] UNIV LAVAL,CTR HOSP,ECOLE PHARM,QUEBEC CITY G1V 4G2,QUEBEC,CANADA

来源：

THERAPEUTIC DRUG MONITORING | 1986年 / 8卷 / 04期

关键词：

D O I：

10.1097/00007691-198612000-00020

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：483 / 489

页数：7

共 32 条

[1] COMPARATIVE PHARMACOKINETICS OF CEFTRIAXONE AFTER SUBCUTANEOUS AND INTRAVENOUS ADMINISTRATION [J].

BORNER, K ;

LODE, H ;

HAMPEL, B ;

PFEUFFER, M ;

KOEPPE, P .

CHEMOTHERAPY, 1985, 31 (04) :237-245

[2] ULTRAFILTRATION VS EQUILIBRIUM DIALYSIS FOR DETERMINATION OF FREE FRACTION [J].

BOWERS, WF ;

FULTON, S ;

THOMPSON, J .

CLINICAL PHARMACOKINETICS, 1984, 9 :49-60

[3] PH LABILITY IN SERUM DURING EQUILIBRIUM DIALYSIS [J].

BRORS, O ;

JACOBSEN, S .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (01) :85-88

[4] PHARMACOKINETICS OF CEFTRIAXONE IN PATIENTS WITH RENAL-FAILURE AND IN THOSE UNDERGOING HEMODIALYSIS [J].

COHEN, D ;

APPEL, GB ;

SCULLY, B ;

NEU, HC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :529-532

[5]

DUDLEY MN, 1982, WOOD I HIST MED, P227

[6] A STUDY OF THE RELATIONSHIP BETWEEN DOSE AND PHARMACOKINETICS OF CEFTRIAXONE [J].

FINDLAY, CD ;

BROWN, RM ;

ALLCOCK, JE ;

LOWE, PA ;

WISE, R .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 9 (01) :57-62

[7] IMPAIRED BINDING OF DRUGS AND ENDOGENOUS LIGANDS IN RENAL DISEASES [J].

GULYASSY, PF ;

DEPNER, TA .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1983, 2 (06) :578-601

[8]

JUDD RL, 1982, CLIN CHEM, V28, P1726

[9]

KOBAYASHI Y, 1974, BIOL APPLICATIONS LI, P109

[10]

KOWALSKY SF, 1985, CLIN PHARMACY, V4, P177

← 1 2 3 4 →